Skip to main content

Table 1 Cell cycle distribution of OCUM-2MD3/L-OHP cells.

From: Anti-tumor effects of CIK combined with oxaliplatin in human oxaliplatin-resistant gastric cancer cells in vivo and in vitro

Cell

Cell cycle

Apoptosis rate (%)

 

G0/G1

S

G2/M

 

Control group

    

   OCUM-2MD3

47.93 ± 0.35

46.83 ± 2.31

5.22 ± 2.50

1.00 ± 0.11

   OCUM-2MD3/L-OHP

66.03 ± 0.28*

10.4 ± 1.06*

23.25 ± 0.78*

5.21 ± 0.55*

Treatment group

    

   OCUM-2MD3

24.80 ± 0.52

49.37 ± 1.59

25.77 ± 1.30Δ

35.53 ± 0.73

   OCUM-2MD3/L-OHP

50.80 ± 2.00

27.80 ± 0.86Δ

21.40 ± 2.79

29.43 ± 0.91*

  1. * Comparisons of different cells in the same group P < 0.05
  2. Δ Comparisons of different cells in different groups P < 0.05
Back to article page

Journal of Experimental & Clinical Cancer Research

ISSN: 1756-9966

Contact us